ClinConnect ClinConnect Logo
Search / Trial NCT06608836

Acute Effects of Cryotherapy on Muscle Properties

Launched by ISTANBUL UNIVERSITY - CERRAHPASA · Sep 20, 2024

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Cryotherapy Muscles Acute Effect Muscle Strength Electromyography

ClinConnect Summary

This clinical trial is looking at how cryotherapy, which is a treatment that uses cold to help with muscle recovery, affects the properties of muscles in healthy people. The researchers want to understand how cryotherapy might change muscle strength and how muscles work right after the treatment.

To be eligible to participate in the study, you need to be between 18 and 35 years old and willing to take part. However, if you have had surgery on your lower leg or foot, you won’t be able to join. If you do participate, you can expect to undergo some assessments to measure your muscle strength and how well your muscles are activated after receiving cryotherapy. The trial is not yet recruiting participants, so it's a great opportunity to learn more about the effects of cold therapy on muscle health.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Being willing to participate in the study
  • Being between the ages of 18 and 35
  • Exclusion Criteria:
  • Having undergone orthopedic surgery involving the lower extremity

About Istanbul University Cerrahpasa

Istanbul University - Cerrahpasa is a prestigious academic institution renowned for its commitment to advancing medical research and education. With a focus on innovative clinical trials, the university harnesses cutting-edge methodologies to address pressing health challenges. Its collaborative environment fosters interdisciplinary research, enabling the development of effective therapeutic strategies and enhancing patient care. The institution's dedication to ethical standards and patient safety underscores its reputation as a leader in clinical research within the region and beyond.

Locations

Patients applied

0 patients applied

Trial Officials

Gamze Aydın, PhD

Principal Investigator

Okan University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported